Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos <i>et al</i>.

Ramiro, Sofia; Mostard, Rémy L M; Landewé, Robert B M

Response to: 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Kaklamanos et al.

Ramiro, Sofia; Mostard, Rémy L M; Landewé, Robert B M.

Afiliação

Ramiro S; Rheumatology, Zuyderland Medical Center, Heerlen, The Netherlands sofiaramiro@gmail.com.
Mostard RLM; Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
Landewé RBM; Department of Pulmonology, Zuyderland Medical Centre Heerlen, Heerlen, The Netherlands.

Ann Rheum Dis ; 82(6): e135, 2023 06.

Article em En | MEDLINE | ID: mdl-33903095

Assuntos

COVID-19; Humanos; Glucocorticoides/uso terapêutico; Síndrome da Liberação de Citocina/tratamento farmacológico; Síndrome da Liberação de Citocina/etiologia; Tratamento Farmacológico da COVID-19; Resultado do Tratamento

Palavras-chave

Covid-19; epidemiology; health care; outcome assessment

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Ann Rheum Dis Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google